Awaiting product image

Article: Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma

€2.42

SKU: product-article-20916 Category:

Description

Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma

Reviews

There are no reviews yet.

Be the first to review “Article: Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma”

Your email address will not be published. Required fields are marked *

Related products